Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies
Summary Context Euthyroid thyroid peroxidase (TPO‐Ab)‐positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism. Previous studies have shown a decrease in TPO‐Ab and improvement of quality‐of‐life (QoL) in L‐T4‐treated hypothyroid patients upon selenium supplem...
Saved in:
| Published in | Clinical endocrinology (Oxford) Vol. 80; no. 3; pp. 444 - 451 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford
Blackwell Publishing Ltd
01.03.2014
Blackwell Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Summary
Context
Euthyroid thyroid peroxidase (TPO‐Ab)‐positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism. Previous studies have shown a decrease in TPO‐Ab and improvement of quality‐of‐life (QoL) in L‐T4‐treated hypothyroid patients upon selenium supplementation.
Objectives
To evaluate in euthyroid TPO‐Ab‐positive women without thyroid medication whether selenite decreases TPO‐Ab and improves QoL.
Design
Randomized, placebo‐controlled, double‐blind study.
Patients and methods
Euthyroid (TSH 0·5–5·0 mU/l, FT4 10–23 pm) women with TPO‐Ab ≥ 100 kU/l were randomized to receive 200 mcg sodium selenite daily (n = 30) or placebo (n = 31) for 6 months. TSH, FT4, TPO‐Ab, selenium (Se), selenoprotein P (SePP) and QoL were measured at baseline, 3, 6 and 9 months.
Results
There were no differences in baseline characteristics between the Se group and the placebo group. During selenite supplementation, serum Se and SePP did not change in the placebo group, but increased in the Se group. TPO‐Ab and TSH did not change significantly in any group. TPO‐Ab in the Se group were 895 (130–6800) at baseline, 1360 (60–7050) kU/l at 6 months, in the placebo group 1090 (120–9200) and 1130 (80–9900) kU/l, respectively (median values with range). TSH in the Se group was 2·1 (0·5–4·3) at baseline, 1·7 (0·0–5·3) mU/l at 6 months, in the placebo group 2·4 (0·7–4·4) and 2·5 (0·2–4·3) mU/l, respectively. QoL was not different between the groups.
Conclusion
Six months selenite supplementation increased markers of selenium status but had no effect on serum TPO‐Ab, TSH or quality‐of‐life in euthyroid TPO‐Ab‐positive women. |
|---|---|
| AbstractList | Summary
Context
Euthyroid thyroid peroxidase (TPO‐Ab)‐positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism. Previous studies have shown a decrease in TPO‐Ab and improvement of quality‐of‐life (QoL) in L‐T4‐treated hypothyroid patients upon selenium supplementation.
Objectives
To evaluate in euthyroid TPO‐Ab‐positive women without thyroid medication whether selenite decreases TPO‐Ab and improves QoL.
Design
Randomized, placebo‐controlled, double‐blind study.
Patients and methods
Euthyroid (TSH 0·5–5·0 mU/l, FT4 10–23 pm) women with TPO‐Ab ≥ 100 kU/l were randomized to receive 200 mcg sodium selenite daily (n = 30) or placebo (n = 31) for 6 months. TSH, FT4, TPO‐Ab, selenium (Se), selenoprotein P (SePP) and QoL were measured at baseline, 3, 6 and 9 months.
Results
There were no differences in baseline characteristics between the Se group and the placebo group. During selenite supplementation, serum Se and SePP did not change in the placebo group, but increased in the Se group. TPO‐Ab and TSH did not change significantly in any group. TPO‐Ab in the Se group were 895 (130–6800) at baseline, 1360 (60–7050) kU/l at 6 months, in the placebo group 1090 (120–9200) and 1130 (80–9900) kU/l, respectively (median values with range). TSH in the Se group was 2·1 (0·5–4·3) at baseline, 1·7 (0·0–5·3) mU/l at 6 months, in the placebo group 2·4 (0·7–4·4) and 2·5 (0·2–4·3) mU/l, respectively. QoL was not different between the groups.
Conclusion
Six months selenite supplementation increased markers of selenium status but had no effect on serum TPO‐Ab, TSH or quality‐of‐life in euthyroid TPO‐Ab‐positive women. Summary Context Euthyroid thyroid peroxidase (TPO-Ab)-positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism. Previous studies have shown a decrease in TPO-Ab and improvement of quality-of-life (QoL) in L-T4-treated hypothyroid patients upon selenium supplementation. Objectives To evaluate in euthyroid TPO-Ab-positive women without thyroid medication whether selenite decreases TPO-Ab and improves QoL. Design Randomized, placebo-controlled, double-blind study. Patients and methods Euthyroid (TSH 0·5-5·0 mU/l, FT4 10-23 pm) women with TPO-Ab ≥ 100 kU/l were randomized to receive 200 mcg sodium selenite daily (n = 30) or placebo (n = 31) for 6 months. TSH, FT4, TPO-Ab, selenium (Se), selenoprotein P (SePP) and QoL were measured at baseline, 3, 6 and 9 months. Results There were no differences in baseline characteristics between the Se group and the placebo group. During selenite supplementation, serum Se and SePP did not change in the placebo group, but increased in the Se group. TPO-Ab and TSH did not change significantly in any group. TPO-Ab in the Se group were 895 (130-6800) at baseline, 1360 (60-7050) kU/l at 6 months, in the placebo group 1090 (120-9200) and 1130 (80-9900) kU/l, respectively (median values with range). TSH in the Se group was 2·1 (0·5-4·3) at baseline, 1·7 (0·0-5·3) mU/l at 6 months, in the placebo group 2·4 (0·7-4·4) and 2·5 (0·2-4·3) mU/l, respectively. QoL was not different between the groups. Conclusion Six months selenite supplementation increased markers of selenium status but had no effect on serum TPO-Ab, TSH or quality-of-life in euthyroid TPO-Ab-positive women. [PUBLICATION ABSTRACT] Euthyroid thyroid peroxidase (TPO-Ab)-positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism. Previous studies have shown a decrease in TPO-Ab and improvement of quality-of-life (QoL) in L-T4-treated hypothyroid patients upon selenium supplementation. To evaluate in euthyroid TPO-Ab-positive women without thyroid medication whether selenite decreases TPO-Ab and improves QoL. Randomized, placebo-controlled, double-blind study. Euthyroid (TSH 0·5-5·0 mU/l, FT4 10-23 pm) women with TPO-Ab ≥ 100 kU/l were randomized to receive 200 mcg sodium selenite daily (n = 30) or placebo (n = 31) for 6 months. TSH, FT4, TPO-Ab, selenium (Se), selenoprotein P (SePP) and QoL were measured at baseline, 3, 6 and 9 months. There were no differences in baseline characteristics between the Se group and the placebo group. During selenite supplementation, serum Se and SePP did not change in the placebo group, but increased in the Se group. TPO-Ab and TSH did not change significantly in any group. TPO-Ab in the Se group were 895 (130-6800) at baseline, 1360 (60-7050) kU/l at 6 months, in the placebo group 1090 (120-9200) and 1130 (80-9900) kU/l, respectively (median values with range). TSH in the Se group was 2·1 (0·5-4·3) at baseline, 1·7 (0·0-5·3) mU/l at 6 months, in the placebo group 2·4 (0·7-4·4) and 2·5 (0·2-4·3) mU/l, respectively. QoL was not different between the groups. Six months selenite supplementation increased markers of selenium status but had no effect on serum TPO-Ab, TSH or quality-of-life in euthyroid TPO-Ab-positive women. Euthyroid thyroid peroxidase (TPO-Ab)-positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism. Previous studies have shown a decrease in TPO-Ab and improvement of quality-of-life (QoL) in L-T4-treated hypothyroid patients upon selenium supplementation.CONTEXTEuthyroid thyroid peroxidase (TPO-Ab)-positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism. Previous studies have shown a decrease in TPO-Ab and improvement of quality-of-life (QoL) in L-T4-treated hypothyroid patients upon selenium supplementation.To evaluate in euthyroid TPO-Ab-positive women without thyroid medication whether selenite decreases TPO-Ab and improves QoL.OBJECTIVESTo evaluate in euthyroid TPO-Ab-positive women without thyroid medication whether selenite decreases TPO-Ab and improves QoL.Randomized, placebo-controlled, double-blind study.DESIGNRandomized, placebo-controlled, double-blind study.Euthyroid (TSH 0·5-5·0 mU/l, FT4 10-23 pm) women with TPO-Ab ≥ 100 kU/l were randomized to receive 200 mcg sodium selenite daily (n = 30) or placebo (n = 31) for 6 months. TSH, FT4, TPO-Ab, selenium (Se), selenoprotein P (SePP) and QoL were measured at baseline, 3, 6 and 9 months.PATIENTS AND METHODSEuthyroid (TSH 0·5-5·0 mU/l, FT4 10-23 pm) women with TPO-Ab ≥ 100 kU/l were randomized to receive 200 mcg sodium selenite daily (n = 30) or placebo (n = 31) for 6 months. TSH, FT4, TPO-Ab, selenium (Se), selenoprotein P (SePP) and QoL were measured at baseline, 3, 6 and 9 months.There were no differences in baseline characteristics between the Se group and the placebo group. During selenite supplementation, serum Se and SePP did not change in the placebo group, but increased in the Se group. TPO-Ab and TSH did not change significantly in any group. TPO-Ab in the Se group were 895 (130-6800) at baseline, 1360 (60-7050) kU/l at 6 months, in the placebo group 1090 (120-9200) and 1130 (80-9900) kU/l, respectively (median values with range). TSH in the Se group was 2·1 (0·5-4·3) at baseline, 1·7 (0·0-5·3) mU/l at 6 months, in the placebo group 2·4 (0·7-4·4) and 2·5 (0·2-4·3) mU/l, respectively. QoL was not different between the groups.RESULTSThere were no differences in baseline characteristics between the Se group and the placebo group. During selenite supplementation, serum Se and SePP did not change in the placebo group, but increased in the Se group. TPO-Ab and TSH did not change significantly in any group. TPO-Ab in the Se group were 895 (130-6800) at baseline, 1360 (60-7050) kU/l at 6 months, in the placebo group 1090 (120-9200) and 1130 (80-9900) kU/l, respectively (median values with range). TSH in the Se group was 2·1 (0·5-4·3) at baseline, 1·7 (0·0-5·3) mU/l at 6 months, in the placebo group 2·4 (0·7-4·4) and 2·5 (0·2-4·3) mU/l, respectively. QoL was not different between the groups.Six months selenite supplementation increased markers of selenium status but had no effect on serum TPO-Ab, TSH or quality-of-life in euthyroid TPO-Ab-positive women.CONCLUSIONSix months selenite supplementation increased markers of selenium status but had no effect on serum TPO-Ab, TSH or quality-of-life in euthyroid TPO-Ab-positive women. |
| Author | Wiersinga, Wilmar M. Schomburg, Lutz Köhrle, Josef Hollenbach, Birgit Endert, Erik Fliers, Eric Eskes, Silvia A. Birnie, Erwin |
| Author_xml | – sequence: 1 givenname: Silvia A. surname: Eskes fullname: Eskes, Silvia A. email: s.eskes@sfg.nl organization: Department of Endocrinology and Metabolism Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands – sequence: 2 givenname: Erik surname: Endert fullname: Endert, Erik organization: Department of Endocrinology and Metabolism Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands – sequence: 3 givenname: Eric surname: Fliers fullname: Fliers, Eric organization: Department of Endocrinology and Metabolism Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands – sequence: 4 givenname: Erwin surname: Birnie fullname: Birnie, Erwin organization: Department of Statistics and Education, St. Franciscus Gasthuis Rotterdam, Rotterdam, The Netherlands – sequence: 5 givenname: Birgit surname: Hollenbach fullname: Hollenbach, Birgit organization: Institute for Experimental Endocrinology, Charité Universitätsmedizin Berlin, Berlin, Germany – sequence: 6 givenname: Lutz surname: Schomburg fullname: Schomburg, Lutz organization: Institute for Experimental Endocrinology, Charité Universitätsmedizin Berlin, Berlin, Germany – sequence: 7 givenname: Josef surname: Köhrle fullname: Köhrle, Josef organization: Institute for Experimental Endocrinology, Charité Universitätsmedizin Berlin, Berlin, Germany – sequence: 8 givenname: Wilmar M. surname: Wiersinga fullname: Wiersinga, Wilmar M. organization: Department of Endocrinology and Metabolism Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28171191$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23844613$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kUtv1DAUhS1URKdTFvwBFAkh0UVa2_EjWVajMiC1hYrX0nKcG9VDxg62o3b-PW5nBqQKvLFlf-fc63uO0IHzDhB6RfApyevMgDsllNbsGZqRSvCSUsEP0AxXGJdYCHaIjmJcYYx5jeULdEirmjFBqhm6-QIDOJugiNM4DrAGl3Sy3hXWFTCl203wtsuP7QpMisWdTbfF_naE4O9tpyMU2iXb-s5CPEbPez1EeLnb5-jb-4uviw_l5aflx8X5ZWkYJaxsdEtrIonUvNZt1wgqDRGsZ7LCPRe4FT3kFqXGOp-5xLTjjegkg7ZuG2aqOXq39R2D_zVBTGpto4Fh0A78FBVhDRWNkNlwjt48QVd-Ci53pwinuTLjjGbq9Y6a2jV0agx2rcNG7YeVgbc7QEejhz5oZ2z8yz18hzQkc2dbzgQfY4BeGbsdagraDopg9RCbyrGpx9iy4uSJYm_6L3bnfmcH2PwfVIuL672i3CpsTHD_R6HDTyVkJbn6cb1UnzFZLq_wlfpe_Qaf1bQr |
| CODEN | CLECAP |
| CitedBy_id | crossref_primary_10_22141_2224_0721_18_2_2022_1158 crossref_primary_10_1089_thy_2023_0556 crossref_primary_10_1186_1745_6215_15_115 crossref_primary_10_1590_2359_3997000000309 crossref_primary_10_1097_MED_0000000000000190 crossref_primary_10_3803_EnM_2016_31_2_213 crossref_primary_10_1038_s41574_019_0311_6 crossref_primary_10_1007_s10354_019_0691_1 crossref_primary_10_3390_nu15143194 crossref_primary_10_1111_cts_12993 crossref_primary_10_11603_bmbr_2706_6290_2020_3_11529 crossref_primary_10_1007_s12020_019_01958_1 crossref_primary_10_1155_2021_9439344 crossref_primary_10_1007_s42000_019_00117_5 crossref_primary_10_1007_s00108_016_0171_2 crossref_primary_10_1007_s40618_015_0285_8 crossref_primary_10_1016_j_imbio_2016_10_004 crossref_primary_10_1007_s40618_022_01987_0 crossref_primary_10_1111_ijcp_14484 crossref_primary_10_1007_s42000_018_0033_5 crossref_primary_10_1210_jc_2017_01736 crossref_primary_10_1089_ct_2014_26_167_170 crossref_primary_10_1089_thy_2016_0256 crossref_primary_10_1016_j_jcte_2018_01_003 crossref_primary_10_1016_j_jtemb_2015_10_003 crossref_primary_10_2478_ahem_2021_0027 crossref_primary_10_3390_nu10060693 crossref_primary_10_1007_s12020_021_02642_z crossref_primary_10_1007_s12020_016_1098_z crossref_primary_10_1016_j_autrev_2020_102649 crossref_primary_10_1097_MED_0000000000000356 crossref_primary_10_3390_diagnostics8040070 crossref_primary_10_1111_jcpt_12765 crossref_primary_10_18231_j_ijcbr_2020_051 crossref_primary_10_1007_s12011_015_0466_5 crossref_primary_10_3390_nu14112234 crossref_primary_10_7759_cureus_11008 |
| Cites_doi | 10.2116/analsci.21.873 10.1016/j.biopsych.2005.06.019 10.1007/BF03345725 10.3945/ajcn.2008.27356 10.1016/j.jtemb.2007.11.003 10.1016/S0140-6736(11)61452-9 10.1210/en.2006-0689 10.1089/ars.2009.2973 10.1016/S0895-4356(98)00097-3 10.1210/jc.2010-0191 10.1046/j.1365-2265.2003.01862.x 10.1111/j.1365-2265.2009.03758.x 10.1002/mnfr.200700465 10.1016/j.beem.2009.08.002 10.1146/annurev.nutr.24.012003.132120 10.1530/eje.0.1440595 10.1093/ajcn/87.2.370 10.1089/thy.2009.0351 10.1089/thy.2007.0040 10.1530/eje.0.1480309 10.1530/EJE-10-1026 10.1038/nrendo.2011.174 10.1016/S0140-6736(00)02490-9 10.1017/S0007114510002618 10.1111/j.1365-2265.1987.tb00784.x 10.1038/ncpendmet0621 10.1210/jcem.87.4.8421 10.1089/thy.2007.0127 10.1677/joe.1.06661 10.1111/j.1365-2265.1995.tb01894.x 10.1530/eje.0.1480389 10.1056/NEJMoa1012985 10.1100/tsw.2010.91 |
| ContentType | Journal Article |
| Copyright | 2013 John Wiley & Sons Ltd 2015 INIST-CNRS 2013 John Wiley & Sons Ltd. Copyright © 2014 John Wiley & Sons Ltd |
| Copyright_xml | – notice: 2013 John Wiley & Sons Ltd – notice: 2015 INIST-CNRS – notice: 2013 John Wiley & Sons Ltd. – notice: Copyright © 2014 John Wiley & Sons Ltd |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP K9. NAPCQ 7X8 |
| DOI | 10.1111/cen.12284 |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1365-2265 |
| EndPage | 451 |
| ExternalDocumentID | 3310015441 23844613 28171191 10_1111_cen_12284 CEN12284 ark_67375_WNG_P01GGM0M_V |
| Genre | article Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Deutsche Forschungsgemeinschaft DFG funderid: GK 1208 TP3 & TP6 – fundername: EnForCé |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 08P 0R~ 10A 1OB 1OC 29B 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AAQQT AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K REN RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION IQODW AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QP K9. NAPCQ 7X8 |
| ID | FETCH-LOGICAL-c4214-9ab281717a58abd9627c164f4730f560b6fe4617a0a0b65702d596d74eb8b94c3 |
| IEDL.DBID | DR2 |
| ISSN | 0300-0664 1365-2265 |
| IngestDate | Thu Jul 10 18:51:01 EDT 2025 Wed Aug 13 06:00:15 EDT 2025 Mon Jul 21 06:04:47 EDT 2025 Wed Apr 02 07:17:42 EDT 2025 Thu Apr 24 23:04:13 EDT 2025 Tue Jul 01 01:33:10 EDT 2025 Wed Jan 22 16:47:00 EST 2025 Wed Oct 30 09:51:30 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Human Endocrine gland Peroxidases Enzyme Antibody Peroxidase Thyroid gland Oxidoreductases Supplementation Endocrinology |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 2013 John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4214-9ab281717a58abd9627c164f4730f560b6fe4617a0a0b65702d596d74eb8b94c3 |
| Notes | istex:325705A550680CEBD7E3598661CA2D53312A6761 ArticleID:CEN12284 ark:/67375/WNG-P01GGM0M-V Deutsche Forschungsgemeinschaft DFG - No. GK 1208 TP3 & TP6 EnForCé ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| PMID | 23844613 |
| PQID | 1526274542 |
| PQPubID | 36523 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_1492696747 proquest_journals_1526274542 pubmed_primary_23844613 pascalfrancis_primary_28171191 crossref_citationtrail_10_1111_cen_12284 crossref_primary_10_1111_cen_12284 wiley_primary_10_1111_cen_12284_CEN12284 istex_primary_ark_67375_WNG_P01GGM0M_V |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | March 2014 |
| PublicationDateYYYYMMDD | 2014-03-01 |
| PublicationDate_xml | – month: 03 year: 2014 text: March 2014 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford |
| PublicationPlace_xml | – name: Oxford – name: England |
| PublicationTitle | Clinical endocrinology (Oxford) |
| PublicationTitleAlternate | Clin Endocrinol |
| PublicationYear | 2014 |
| Publisher | Blackwell Publishing Ltd Blackwell Wiley Subscription Services, Inc |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell – name: Wiley Subscription Services, Inc |
| References | Bonfig, W., Gärtner, R. & Schmidt, H. (2010) Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. The Scientific World Journal, 10, 990-996. Köhrle, J. & Gärtner, R. (2009) Selenium and thyroid. Best Practice & Research. Clinical Endocrinology & Metabolism, 23, 815-827. Derumeaux, H., Valeix, P., Castetbon, K. et al. (2003) Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. European Journal of Endocrinology, 148, 309-315. Krohn, K., Maier, J. & Paschke, R. (2007) Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors. Nature Clinical Practice. Endocrinology & Metabolism, 3, 713-720. Rayman, M.P. (2012) Selenium and human health. Lancet, 379, 1256-1268. Riese, C., Michaelis, M., Mentrup, B. et al. (2006) Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues. Endocrinology, 147, 5883-5892. Schomburg, L. (2011) Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nature Reviews. Endocrinology, 8, 160-171. Nacamulli, D., Mian, C., Petricca, D. et al. (2010) Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clinical Endocrinology, 73, 535-539. Hendriksen, M.A.H., Wilson-van den Hooven, E.C. & van der A, D.L. (2011) Salt- and iodine intake among adults in Doetinchem in 2010. Publication of National Institute for Public Health and the Environment. Ministry of Health, Welfare and Sport, 1-35. Papp, L.V., Holmgren, A. & Khanna, K.K. (2010) Selenium and selenoproteins in health and disease. Antioxidants & Redox Signaling, 12, 793-795. Aaronson, N.K., Muller, M.J., Cohen, P.D.A. et al. (1998) Translation, validation and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease publications. Journal of Clinical Epidemiology, 51, 1055-1068. Berghout, A., Wiersinga, W.M., Smits, N.J. et al. (1987) Determinants of thyroid volume as measured by ultrasonography in healthy adults in a non-iodine deficient area. Clinical Endocrinology, 26, 273-280. Hollenbach, B., Morgenthaler, N.G., Struck, J. et al. (2008) New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. Journal of Trace Elements in Medicine and Biology, 22, 24-32. Rayman, M., Thompson, A., Warren-Perry, M. et al. (2006) Impact of selenium on mood and quality of life: a randomized, controlled trial. Biological Psychiatry, 59, 147-154. Turker, O., Kumanlioglu, K., Karapolat, I. et al. (2006) Selenium treatment in autoimmune thyroiditis: a 9-month follow-up with variable doses. The Journal of Endocrinology, 190, 151-156. Duntas, L.H., Mantzou, E. & Koutras, D.A. (2003) Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. European Journal of Endocrinology, 148, 389-393. Combs, G.F., Midthune, D.N., Patterson, K.Y. et al. (2009) Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in adults. American Journal of Clinical Nutrition, 89, 1808-1814. Rayman, M.P. (2000) The importance of selenium to human health. Lancet, 356, 233-241. Rayman, M.P., Thompson, A.J., Bekaert, B. et al. (2008) Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. American Journal of Clinical Nutrition, 87, 370-378. Duntas, L.H. (2010) Selenium and the thyroid: a close-knit connection. Journal of Clinical Endocrinology and Metabolism, 95, 1-9. Petricca, D., Nacamulli, D., Mian, C. et al. (2012) Effects of selenium supplementation on the natural course of autoimmune thyroiditis: a short review. Journal of Endocrinological Investigation, 35, 419-424. Marcocci, C., Kahaly, G.J., Krassas, G.E. et al. (2011) Selenium and the course of mild Graves' orbitopathy. New England Journal of Medicine, 364, 1920-1931. Karanikas, G., Schuetz, M., Kontur, S. et al. (2008) No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid, 18, 7-12. Stosnach, H. (2005) Environmental trace-element analysis using a benchtop total reflection X-ray fluorescence spectrometer. Analytical Sciences, 21, 873-876. Wiersinga, W.M., Podoba, J., Srbecky, M. et al. (2001) A survey of iodine intake and thyroid volume in Dutch schoolchildren: reference values in an iodine-sufficient area and the effect of puberty. European Journal of Endocrinology, 144, 595-603. Mazokopakis, E.E., Papadakis, J.A., Papadomanolaki, M.G. et al. (2007) Effects of 12 months treatment with L-Selenomethionine on serum anti-TPO levels in patients with Hashimoto's thyroiditis. Thyroid, 17, 609-612. Vanderpump, M.P., Tunbridge, W.M. & French, J.M. (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology, 43, 55-68. Fiore, E., Rago, T., Scutari, M. et al. (2009) Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases. Journal of Endocrinological Investigation, 32, 344-351. Rasmussen, L.B., Schomburg, L., Köhrle, J. et al. (2011) Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. European Journal of Endocrinology, 164, 585-590. Hoeflich, J., Hollenbach, B., Behrends, T. et al. (2010) The choice of biomarkers determines the selenium status in young German vegans and vegetarians. British Journal of Nutrition, 104, 1601-1604. Strieder, T.G.A., Prummel, M.F., Tijssen, J.G.P. et al. (2003) Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid diseases. Clinical Endocrinology, 59, 396-401. Gärtner, R., Gasnier, B.C.H., Dietrich, J.W. et al. (2002) Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. Journal of Clinical Endocrinology and Metabolism, 87, 1687-1691. Burk, R.F. & Hill, K.E. (2005) Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annual Review of Nutrition, 25, 215-235. Schomburg, L. & Köhrle, J. (2008) On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Molecular Nutrition & Food Research, 52, 1-12. Toulis, K.A., Anastasilakis, A.D., Tzellos, T.G. et al. (2010) Selenium supplementation in the treatment of hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid, 20, 1163-1173. 2010; 12 2009; 23 2007; 17 2009; 89 2001; 144 2010; 10 2000; 356 2011 2008; 18 2010; 104 2006; 59 2003; 59 2005; 21 2008; 52 2012; 35 2011; 8 2005; 25 2010; 20 2009; 32 2006; 190 2002; 87 1995; 43 2008; 87 2008; 22 2007; 3 2003; 148 2012; 379 1998; 51 2010; 73 2010; 95 2011; 364 1987; 26 2006; 147 2011; 164 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_34_1 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 Petricca D. (e_1_2_6_11_1) 2012; 35 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_9_1 e_1_2_6_8_1 Hendriksen M.A.H. (e_1_2_6_32_1) 2011 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 Gärtner R. (e_1_2_6_13_1) 2002; 87 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
| References_xml | – reference: Marcocci, C., Kahaly, G.J., Krassas, G.E. et al. (2011) Selenium and the course of mild Graves' orbitopathy. New England Journal of Medicine, 364, 1920-1931. – reference: Stosnach, H. (2005) Environmental trace-element analysis using a benchtop total reflection X-ray fluorescence spectrometer. Analytical Sciences, 21, 873-876. – reference: Rayman, M.P. (2000) The importance of selenium to human health. Lancet, 356, 233-241. – reference: Duntas, L.H. (2010) Selenium and the thyroid: a close-knit connection. Journal of Clinical Endocrinology and Metabolism, 95, 1-9. – reference: Turker, O., Kumanlioglu, K., Karapolat, I. et al. (2006) Selenium treatment in autoimmune thyroiditis: a 9-month follow-up with variable doses. The Journal of Endocrinology, 190, 151-156. – reference: Rayman, M., Thompson, A., Warren-Perry, M. et al. (2006) Impact of selenium on mood and quality of life: a randomized, controlled trial. Biological Psychiatry, 59, 147-154. – reference: Schomburg, L. (2011) Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nature Reviews. Endocrinology, 8, 160-171. – reference: Aaronson, N.K., Muller, M.J., Cohen, P.D.A. et al. (1998) Translation, validation and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease publications. Journal of Clinical Epidemiology, 51, 1055-1068. – reference: Petricca, D., Nacamulli, D., Mian, C. et al. (2012) Effects of selenium supplementation on the natural course of autoimmune thyroiditis: a short review. Journal of Endocrinological Investigation, 35, 419-424. – reference: Krohn, K., Maier, J. & Paschke, R. (2007) Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors. Nature Clinical Practice. Endocrinology & Metabolism, 3, 713-720. – reference: Derumeaux, H., Valeix, P., Castetbon, K. et al. (2003) Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. European Journal of Endocrinology, 148, 309-315. – reference: Wiersinga, W.M., Podoba, J., Srbecky, M. et al. (2001) A survey of iodine intake and thyroid volume in Dutch schoolchildren: reference values in an iodine-sufficient area and the effect of puberty. European Journal of Endocrinology, 144, 595-603. – reference: Hollenbach, B., Morgenthaler, N.G., Struck, J. et al. (2008) New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. Journal of Trace Elements in Medicine and Biology, 22, 24-32. – reference: Combs, G.F., Midthune, D.N., Patterson, K.Y. et al. (2009) Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in adults. American Journal of Clinical Nutrition, 89, 1808-1814. – reference: Rayman, M.P., Thompson, A.J., Bekaert, B. et al. (2008) Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. American Journal of Clinical Nutrition, 87, 370-378. – reference: Strieder, T.G.A., Prummel, M.F., Tijssen, J.G.P. et al. (2003) Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid diseases. Clinical Endocrinology, 59, 396-401. – reference: Schomburg, L. & Köhrle, J. (2008) On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Molecular Nutrition & Food Research, 52, 1-12. – reference: Mazokopakis, E.E., Papadakis, J.A., Papadomanolaki, M.G. et al. (2007) Effects of 12 months treatment with L-Selenomethionine on serum anti-TPO levels in patients with Hashimoto's thyroiditis. Thyroid, 17, 609-612. – reference: Nacamulli, D., Mian, C., Petricca, D. et al. (2010) Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clinical Endocrinology, 73, 535-539. – reference: Köhrle, J. & Gärtner, R. (2009) Selenium and thyroid. Best Practice & Research. Clinical Endocrinology & Metabolism, 23, 815-827. – reference: Gärtner, R., Gasnier, B.C.H., Dietrich, J.W. et al. (2002) Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. Journal of Clinical Endocrinology and Metabolism, 87, 1687-1691. – reference: Karanikas, G., Schuetz, M., Kontur, S. et al. (2008) No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid, 18, 7-12. – reference: Vanderpump, M.P., Tunbridge, W.M. & French, J.M. (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology, 43, 55-68. – reference: Berghout, A., Wiersinga, W.M., Smits, N.J. et al. (1987) Determinants of thyroid volume as measured by ultrasonography in healthy adults in a non-iodine deficient area. Clinical Endocrinology, 26, 273-280. – reference: Rayman, M.P. (2012) Selenium and human health. Lancet, 379, 1256-1268. – reference: Bonfig, W., Gärtner, R. & Schmidt, H. (2010) Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. The Scientific World Journal, 10, 990-996. – reference: Fiore, E., Rago, T., Scutari, M. et al. (2009) Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases. Journal of Endocrinological Investigation, 32, 344-351. – reference: Toulis, K.A., Anastasilakis, A.D., Tzellos, T.G. et al. (2010) Selenium supplementation in the treatment of hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid, 20, 1163-1173. – reference: Riese, C., Michaelis, M., Mentrup, B. et al. (2006) Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues. Endocrinology, 147, 5883-5892. – reference: Rasmussen, L.B., Schomburg, L., Köhrle, J. et al. (2011) Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. European Journal of Endocrinology, 164, 585-590. – reference: Hoeflich, J., Hollenbach, B., Behrends, T. et al. (2010) The choice of biomarkers determines the selenium status in young German vegans and vegetarians. British Journal of Nutrition, 104, 1601-1604. – reference: Hendriksen, M.A.H., Wilson-van den Hooven, E.C. & van der A, D.L. (2011) Salt- and iodine intake among adults in Doetinchem in 2010. Publication of National Institute for Public Health and the Environment. Ministry of Health, Welfare and Sport, 1-35. – reference: Duntas, L.H., Mantzou, E. & Koutras, D.A. (2003) Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. European Journal of Endocrinology, 148, 389-393. – reference: Burk, R.F. & Hill, K.E. (2005) Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annual Review of Nutrition, 25, 215-235. – reference: Papp, L.V., Holmgren, A. & Khanna, K.K. (2010) Selenium and selenoproteins in health and disease. Antioxidants & Redox Signaling, 12, 793-795. – volume: 32 start-page: 344 year: 2009 end-page: 351 article-title: Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto‐antibodies in patients with nodular thyroid diseases publication-title: Journal of Endocrinological Investigation – volume: 379 start-page: 1256 year: 2012 end-page: 1268 article-title: Selenium and human health publication-title: Lancet – volume: 8 start-page: 160 year: 2011 end-page: 171 article-title: Selenium, selenoproteins and the thyroid gland: interactions in health and disease publication-title: Nature Reviews. Endocrinology – volume: 3 start-page: 713 year: 2007 end-page: 720 article-title: Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors publication-title: Nature Clinical Practice. Endocrinology & Metabolism – volume: 52 start-page: 1 year: 2008 end-page: 12 article-title: On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health publication-title: Molecular Nutrition & Food Research – volume: 148 start-page: 309 year: 2003 end-page: 315 article-title: Association of selenium with thyroid volume and echostructure in 35‐ to 60‐year‐old French adults publication-title: European Journal of Endocrinology – volume: 356 start-page: 233 year: 2000 end-page: 241 article-title: The importance of selenium to human health publication-title: Lancet – start-page: 1 year: 2011 end-page: 35 article-title: Salt‐ and iodine intake among adults in Doetinchem in 2010. Publication of National Institute for Public Health and the Environment publication-title: Ministry of Health, Welfare and Sport – volume: 73 start-page: 535 year: 2010 end-page: 539 article-title: Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis publication-title: Clinical Endocrinology – volume: 23 start-page: 815 year: 2009 end-page: 827 article-title: Selenium and thyroid publication-title: Best Practice & Research. Clinical Endocrinology & Metabolism – volume: 10 start-page: 990 year: 2010 end-page: 996 article-title: Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis publication-title: The Scientific World Journal – volume: 89 start-page: 1808 year: 2009 end-page: 1814 article-title: Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in adults publication-title: American Journal of Clinical Nutrition – volume: 147 start-page: 5883 year: 2006 end-page: 5892 article-title: Selenium‐dependent pre‐ and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues publication-title: Endocrinology – volume: 59 start-page: 147 year: 2006 end-page: 154 article-title: Impact of selenium on mood and quality of life: a randomized, controlled trial publication-title: Biological Psychiatry – volume: 18 start-page: 7 year: 2008 end-page: 12 article-title: No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis publication-title: Thyroid – volume: 12 start-page: 793 year: 2010 end-page: 795 article-title: Selenium and selenoproteins in health and disease publication-title: Antioxidants & Redox Signaling – volume: 43 start-page: 55 year: 1995 end-page: 68 article-title: The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey publication-title: Clinical Endocrinology – volume: 26 start-page: 273 year: 1987 end-page: 280 article-title: Determinants of thyroid volume as measured by ultrasonography in healthy adults in a non‐iodine deficient area publication-title: Clinical Endocrinology – volume: 95 start-page: 1 year: 2010 end-page: 9 article-title: Selenium and the thyroid: a close‐knit connection publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 51 start-page: 1055 year: 1998 end-page: 1068 article-title: Translation, validation and norming of the Dutch language version of the SF‐36 Health Survey in community and chronic disease publications publication-title: Journal of Clinical Epidemiology – volume: 364 start-page: 1920 year: 2011 end-page: 1931 article-title: Selenium and the course of mild Graves' orbitopathy publication-title: New England Journal of Medicine – volume: 59 start-page: 396 year: 2003 end-page: 401 article-title: Risk factors for and prevalence of thyroid disorders in a cross‐sectional study among healthy female relatives of patients with autoimmune thyroid diseases publication-title: Clinical Endocrinology – volume: 87 start-page: 1687 year: 2002 end-page: 1691 article-title: Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 25 start-page: 215 year: 2005 end-page: 235 article-title: Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis publication-title: Annual Review of Nutrition – volume: 164 start-page: 585 year: 2011 end-page: 590 article-title: Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency publication-title: European Journal of Endocrinology – volume: 22 start-page: 24 year: 2008 end-page: 32 article-title: New assay for the measurement of selenoprotein P as a sepsis biomarker from serum publication-title: Journal of Trace Elements in Medicine and Biology – volume: 20 start-page: 1163 year: 2010 end-page: 1173 article-title: Selenium supplementation in the treatment of hashimoto's thyroiditis: a systematic review and a meta‐analysis publication-title: Thyroid – volume: 35 start-page: 419 year: 2012 end-page: 424 article-title: Effects of selenium supplementation on the natural course of autoimmune thyroiditis: a short review publication-title: Journal of Endocrinological Investigation – volume: 17 start-page: 609 year: 2007 end-page: 612 article-title: Effects of 12 months treatment with L‐Selenomethionine on serum anti‐TPO levels in patients with Hashimoto's thyroiditis publication-title: Thyroid – volume: 144 start-page: 595 year: 2001 end-page: 603 article-title: A survey of iodine intake and thyroid volume in Dutch schoolchildren: reference values in an iodine‐sufficient area and the effect of puberty publication-title: European Journal of Endocrinology – volume: 87 start-page: 370 year: 2008 end-page: 378 article-title: Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom publication-title: American Journal of Clinical Nutrition – volume: 190 start-page: 151 year: 2006 end-page: 156 article-title: Selenium treatment in autoimmune thyroiditis: a 9‐month follow‐up with variable doses publication-title: The Journal of Endocrinology – volume: 148 start-page: 389 year: 2003 end-page: 393 article-title: Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis publication-title: European Journal of Endocrinology – volume: 21 start-page: 873 year: 2005 end-page: 876 article-title: Environmental trace‐element analysis using a benchtop total reflection X‐ray fluorescence spectrometer publication-title: Analytical Sciences – volume: 104 start-page: 1601 year: 2010 end-page: 1604 article-title: The choice of biomarkers determines the selenium status in young German vegans and vegetarians publication-title: British Journal of Nutrition – ident: e_1_2_6_23_1 doi: 10.2116/analsci.21.873 – ident: e_1_2_6_34_1 doi: 10.1016/j.biopsych.2005.06.019 – ident: e_1_2_6_20_1 doi: 10.1007/BF03345725 – ident: e_1_2_6_30_1 doi: 10.3945/ajcn.2008.27356 – ident: e_1_2_6_25_1 doi: 10.1016/j.jtemb.2007.11.003 – ident: e_1_2_6_3_1 doi: 10.1016/S0140-6736(11)61452-9 – ident: e_1_2_6_36_1 doi: 10.1210/en.2006-0689 – ident: e_1_2_6_2_1 doi: 10.1089/ars.2009.2973 – ident: e_1_2_6_22_1 doi: 10.1016/S0895-4356(98)00097-3 – ident: e_1_2_6_26_1 doi: 10.1210/jc.2010-0191 – ident: e_1_2_6_9_1 doi: 10.1046/j.1365-2265.2003.01862.x – ident: e_1_2_6_17_1 doi: 10.1111/j.1365-2265.2009.03758.x – ident: e_1_2_6_28_1 doi: 10.1002/mnfr.200700465 – ident: e_1_2_6_6_1 doi: 10.1016/j.beem.2009.08.002 – ident: e_1_2_6_27_1 doi: 10.1146/annurev.nutr.24.012003.132120 – ident: e_1_2_6_31_1 doi: 10.1530/eje.0.1440595 – ident: e_1_2_6_29_1 doi: 10.1093/ajcn/87.2.370 – ident: e_1_2_6_12_1 doi: 10.1089/thy.2009.0351 – ident: e_1_2_6_16_1 doi: 10.1089/thy.2007.0040 – ident: e_1_2_6_7_1 doi: 10.1530/eje.0.1480309 – ident: e_1_2_6_8_1 doi: 10.1530/EJE-10-1026 – ident: e_1_2_6_5_1 doi: 10.1038/nrendo.2011.174 – ident: e_1_2_6_4_1 doi: 10.1016/S0140-6736(00)02490-9 – ident: e_1_2_6_24_1 doi: 10.1017/S0007114510002618 – ident: e_1_2_6_21_1 doi: 10.1111/j.1365-2265.1987.tb00784.x – ident: e_1_2_6_33_1 doi: 10.1038/ncpendmet0621 – start-page: 1 year: 2011 ident: e_1_2_6_32_1 article-title: Salt‐ and iodine intake among adults in Doetinchem in 2010. Publication of National Institute for Public Health and the Environment publication-title: Ministry of Health, Welfare and Sport – volume: 87 start-page: 1687 year: 2002 ident: e_1_2_6_13_1 article-title: Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations publication-title: Journal of Clinical Endocrinology and Metabolism doi: 10.1210/jcem.87.4.8421 – volume: 35 start-page: 419 year: 2012 ident: e_1_2_6_11_1 article-title: Effects of selenium supplementation on the natural course of autoimmune thyroiditis: a short review publication-title: Journal of Endocrinological Investigation – ident: e_1_2_6_18_1 doi: 10.1089/thy.2007.0127 – ident: e_1_2_6_15_1 doi: 10.1677/joe.1.06661 – ident: e_1_2_6_10_1 doi: 10.1111/j.1365-2265.1995.tb01894.x – ident: e_1_2_6_14_1 doi: 10.1530/eje.0.1480389 – ident: e_1_2_6_35_1 doi: 10.1056/NEJMoa1012985 – ident: e_1_2_6_19_1 doi: 10.1100/tsw.2010.91 |
| SSID | ssj0005807 |
| Score | 2.3193014 |
| Snippet | Summary
Context
Euthyroid thyroid peroxidase (TPO‐Ab)‐positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism.... Euthyroid thyroid peroxidase (TPO-Ab)-positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism. Previous studies have... Summary Context Euthyroid thyroid peroxidase (TPO-Ab)-positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism.... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 444 |
| SubjectTerms | Adult Aged Autoantibodies - blood Biological and medical sciences Dietary Supplements Disease Progression Drug therapy Endocrinopathies Female Fundamental and applied biological sciences. Psychology Hormones Humans Hypothyroidism - blood Hypothyroidism - immunology Hypothyroidism - prevention & control Iodide Peroxidase - immunology Medical sciences Middle Aged Older people Selenium Sodium Selenite - administration & dosage Sodium Selenite - blood Thyroid Gland - drug effects Thyroid Gland - physiology Thyroiditis, Autoimmune - blood Thyroiditis, Autoimmune - immunology Thyroiditis, Autoimmune - prevention & control Vertebrates: endocrinology Young Adult |
| Title | Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies |
| URI | https://api.istex.fr/ark:/67375/WNG-P01GGM0M-V/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcen.12284 https://www.ncbi.nlm.nih.gov/pubmed/23844613 https://www.proquest.com/docview/1526274542 https://www.proquest.com/docview/1492696747 |
| Volume | 80 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9RAEB9KBfGLb21sLVFE_JIjj9lNgp-ktFeEO3xV-0FYdjcbOCo5udxB6V_vzOZRTyqI30J2Epidx_5md3YG4FVmBOYytlFuyjLCQmaRcbKOEjRcfaTWte_eMJvL0zN8fy7Od-DtcBemqw8xbrixZXh_zQauTfubkVvXTJKUvCv5X87VYkD06bp0lOivSmd8c1pK7KsKcRbP-OXWWnSLp_WScyN1S9NTd30tbgKe2zjWL0Qn9-D7wEKXf3Ix2azNxF79Ud3xP3m8D3d7gBq-6zTqAey45iHcnvVH8I_g42deqAiohi03BO2Sz1m64aIJ3YbkvlouKho0vMPThrzRGw5vuSr55aKilTMkiS7MknMYH8PZyfGXo9Oo78sQWUwTjEpt0iKhOFCLQpuK2_dYirpqJG9RE4IysnZIyEjHmp5FHqeVKGWVozOFKdFmT2C3WTZuD8IMLVoaRRQ1eY-itC4jjEewzjgUugzgzSAhZfui5dw744cagheaIuWnKICXI-nPrlLHTUSvvZhHCr264NS2XKhv86n6ECfT6Syeqa8BHG7pwfiB55yC3AAOBsVQvdm3isAQ9zISmAbwYhwmg-VTGN245YZouERjKSmMC-Bpp1DXP88KCs-TjNj2avF3RtTR8dw_PPt30n24Q3APuwy6A9hdrzbuOUGqtTn0tvMLdY4Z1g |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZaxRBEC5iAuqL9zEa4ygivswyR_Uc4IuEZFfNLB6J5kWa7p4eWCKzsgcEf71VPUdciSC-Dds1C9VV1f1VT_VXAC8SLTBLQxNkuigCzNMk0Datgwg1s4_UqnbdG8ppOjnBd6fidAte93dhWn6I4cCNI8Ot1xzgfCD9W5Qb24yimJbXK7DDHb1dQvXpgjxKdJelE747nabY8QpxHc_w6sZutMMTe87VkWpJE1S3nS0ug56bSNZtRYc34VuvRFuBcjZar_TI_PyD3_F_tbwFNzqM6r9pneo2bNnmDlwtu6_wd-HjZ96rCKv6S-4J2tafs4H9WePbNZl-MZ9VNKj5kGfp81mv3__KxOTns4o2T5-MOtNzLmO8ByeHB8f7k6BrzRAYjCMMCqXjPKJUUIlc6Yo7-BhKvGqkBaMmEKXT2iKBIxUqehZZGFeiSKsMrc51gSa5D9vNvLEPwU_QoKFRRFHTApIXxiYE8wjZaYtCFR686k0kTcdbzu0zvss-f6Epkm6KPHg-iP5oyTouE3rp7DxIqMUZV7dlQn6djuWHMBqPy7CUXzzY23CE4QWnOeW5Huz2niG7yF9KwkPczkhg7MGzYZhilj_EqMbO1yTDLI1FSpmcBw9aj7r48ySnDD1KSG3nF39XRO4fTN3Do38XfQrXJsflkTx6O33_GK4T-sO2oG4XtleLtX1CCGul91wg_QIA-x3x |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZaxRBEC5iAsGXeOtojKOI-DLLHNU9M_gkSXbjsUs8onkQmu6eHlgSZsMeEPz1Vs0VVyKIb8N2zUJ1VXV_1VP9FcDLxAhMZWiD1OR5gJlMAuNkGURomH2k1GXdvWE8kUcn-P5UnG7Am-4uTMMP0R-4cWTU6zUH-EVR_hbk1lWDKKbV9QZsoQwzdumDz1fcUaK9K53w1WkpsaUV4jKe_tW1zWiL5_WSiyP1guanbBpbXIc814FsvRMNb8GPToemAOVssFqagf35B73jfyp5G3ZahOq_bVzqDmy46i5sj9tv8Pfg0xfeqQip-gvuCNpUn7N5_WnluxUZfj6bFjRo-Ihn4fNJr9_9yrTkl9OCtk6fTDo1My5ivA8nw8Ov-0dB25ghsBhHGOTaxFlEiaAWmTYF9--xlHaVSMtFSRDKyNIhQSMdanoWaRgXIpdFis5kJkebPIDNala5R-AnaNHSKKIoafnIcusSAnmE64xDoXMPXncWUrZlLefmGeeqy15oilQ9RR686EUvGqqO64Re1WbuJfT8jGvbUqG-T0bqOIxGo3E4Vt882Fvzg_6FWnPKcj3Y7RxDtXG_UISGuJmRwNiD5_0wRSx_htGVm61Ihjkac0l5nAcPG4e6-vMko_w8Skjt2i3-rojaP5zUD4__XfQZbB8fDNXHd5MPT-AmQT9squl2YXM5X7mnBK-WZq8Oo1-tiRyp |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Selenite+supplementation+in+euthyroid+subjects+with+thyroid+peroxidase+antibodies&rft.jtitle=Clinical+endocrinology+%28Oxford%29&rft.au=Eskes%2C+Silvia+A&rft.au=Endert%2C+Erik&rft.au=Fliers%2C+Eric&rft.au=Birnie%2C+Erwin&rft.date=2014-03-01&rft.eissn=1365-2265&rft.volume=80&rft.issue=3&rft.spage=444&rft_id=info:doi/10.1111%2Fcen.12284&rft_id=info%3Apmid%2F23844613&rft.externalDocID=23844613 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-0664&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-0664&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-0664&client=summon |